Amylyx Pharmaceuticals, Inc.

Q3 2023 13F Holders

Symbol
AMLX
CUSIP
03237H101
Type
Equity
Class
COM
Num filers
176
Total reported value, excl. options
$1.08B
Manager Report Date Value ($000) Shares